Showing results (91-100 of 127) with videos related to
Sort By:
Pageof 13
Cancer Investigation|January 1, 1990
Randomized phase II study of a combination of cisplatin (DDP), 5-fluorouracil (5-FU), and allopurinol (HPP) versus 5-FU in advanced colorectal carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group studyH Bleiberg, B Vanderlinden, M Buyse, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1992
Efficacy of twice daily versus three times daily oral ondansetron in the prevention of chemotherapy induced emesis: a randomized, single-blind, multicentre study. The Ondansetron International Emesis Study GroupM A Dicato, S Kaasa, E Campora, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomitingF Hulstaert, S Van Belle, H Bleiberg, et al.Acta Gastro-Enterologica Belgica|May 10, 2012
A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancerH Bleiberg, A Vandebroek, I Deleu, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1993
Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group StudyB G Taal, R A Audisio, H Bleiberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II studyC Louvet, T André, G Lledo, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 1991
Hepatic artery ligation with and without portal infusion of 5-FU. A randomized study in patients with unresectable liver metastases from colorectal carcinoma. The E.O.R.T.C. Gastrointestinal Cancer Cooperative Group (G.I. Group)A Gerard, M Buyse, J C Pector, et al.British Journal of Cancer|August 17, 2001
Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) +/- folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patientsM A Bensmaïne, M Marty, A de Gramont, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 1989
Adjuvant radiotherapy and chemotherapy in resectable gastric cancer. A randomized trial of the gastro-intestinal tract cancer cooperative group of the EORTCH Bleiberg, J C Goffin, O Dalesio, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Modulation of high-dose infusional fluorouracil by low-dose methotrexate in patients with advanced or metastatic colorectal cancer: final results of a randomized European Organization for Research and Treatment of Cancer StudyG Blijham, T Wagener, J Wils, et al.Pageof 13